News Archives - Page 204 of 1183 - BioHealth Innovation

News

July 30, 2021

Emergent BioSolutions to restart COVID-19 vaccine manufacturing in Baltimore – Technical.ly Baltimore

Maryland biotech company Emergent BioSolutions said on Thursday that it was approved by the U.S. Food and Drug Administration (FDA)…

admin

Love0

News

July 30, 2021

Shuttle Pharma Awarded a New Patent for Selective Inhibitors for Cancer Treatment

ROCKVILLE, Md., July 29, 2021 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc (Shuttle Pharma), a Maryland-based developer of new drugs for…

admin

Love0

News

July 30, 2021

Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility · BioBuzz

GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview…

admin

Love0

News

July 30, 2021

The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines · BioBuzz

Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role…

admin

Love0

News

July 29, 2021

Boston Properties to Acquire Maryland Biotech Campus for $117M – Commercial Observer

Boston Properties (BXP) is set to acquire the Shady Grove Bio+Tech Campus, a seven-building, 435,000-square-foot office park in Rockville, Md.,…

admin

Love0

News

July 29, 2021

The Delta Variant: How Companies Should Respond

The rapidly spreading Delta variant is forcing employers to rethink their strategies for handling the pandemic. Policies they should reconsider…

admin

Love0

News

July 29, 2021

Why is the delta variant of Covid-19 more transmissible? — Quartz India

The delta variant spreads much faster than other Covid-19 strains—and scientists may now know why. People infected with the delta…

admin

Love0

News

July 29, 2021

Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients

ROCKVILLE, Md. and CHESTERBROOK, Pa., July 26, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on…

admin

Love0

News

July 29, 2021

Check-out JLABS quarterly portfolio update

Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of ompanies across our 13…

admin

Love0

News

July 29, 2021

Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics

ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms,…

admin

Love0

News

Emergent BioSolutions to restart COVID-19 vaccine manufacturing in Baltimore – Technical.ly Baltimore

Shuttle Pharma Awarded a New Patent for Selective Inhibitors for Cancer Treatment

Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility · BioBuzz

The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines · BioBuzz

Boston Properties to Acquire Maryland Biotech Campus for $117M – Commercial Observer

The Delta Variant: How Companies Should Respond

Why is the delta variant of Covid-19 more transmissible? — Quartz India

Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients

Check-out JLABS quarterly portfolio update

Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search